Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Who Previously Progressed on Erlotinib

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-14-3281 ◽

2015 ◽

Vol 21 (19) ◽

pp. 4321-4326 ◽

Author(s):

Primo N. Lara ◽

Jeff Longmate ◽

Philip C. Mack ◽

Karen Kelly ◽

Mark A. Socinski ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Download Full-text

Phase II study of the AKT inhibitor MK-2206 plus erlotinib (E) in patients (pts) with advanced non-small cell lung cancer (NSCLC) who progressed on prior erlotinib: A California Cancer Consortium Phase II trial (NCI 8698).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.8015 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 8015-8015 ◽

Author(s):

Primo Lara ◽

Jeff Longmate ◽

Philip C. Mack ◽

Karen Kelly ◽

Mark A. Socinski ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Phase Ii Study ◽

Small Cell Lung ◽

Download Full-text

Interim analysis of a phase II study of induction weekly paclitaxel/carboplatin regimens followed by maintenance weekly paclitaxel for advanced and metastatic non[ndash ]small cell lung cancer

Seminars in Oncology ◽

10.1053/sonc.2001.27610 ◽

2001 ◽

Vol 28 (4L) ◽

pp. 14-16

Author(s):

Chandra P. Belani

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Interim Analysis ◽

Phase Ii Study ◽

Weekly Paclitaxel ◽

Small Cell Lung

Download Full-text

Faculty of 1000 evaluation for A phase II study of bevacizumab and erlotinib as initial treatment for metastatic non-squamous, non-small cell lung cancer with serum proteomic evaluation.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717976259.793472648 ◽

2013 ◽

Author(s):

James Spicer

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Initial Treatment ◽

Phase Ii Study ◽

Small Cell Lung

Download Full-text

A phase II study with gemcitabine and split-dose cisplatin in patients with advanced non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2006.06.013 ◽

2006 ◽

Vol 54 (1) ◽

pp. 57-62 ◽

Author(s):

Jung Han Kim ◽

Dong Hun Lee ◽

Hyun Chun Shin ◽

Jung Hye Kwon ◽

Joo Young Jung ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Download Full-text

115P Survival data from EMPOWER-Lung 4: Phase II study of cemiplimab plus ipilimumab in the second-line (2L) treatment of advanced non-small cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(21)01957-2 ◽

2021 ◽

Vol 16 (4) ◽

pp. S760

Author(s):

B.Y. Shim ◽

S. Lee ◽

J. de Castro Carpeño ◽

C-H. Chiu ◽

M. Cobo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Survival Data ◽

Phase Ii Study ◽

Second Line ◽

Small Cell Lung

Download Full-text

Final survival results for the LURET phase II study of vandetanib in previously treated patients with RET-rearranged advanced non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2021.03.002 ◽

2021 ◽

Vol 155 ◽

pp. 40-45

Author(s):

Kiyotaka Yoh ◽

Takashi Seto ◽

Miyako Satouchi ◽

Makoto Nishio ◽

Noboru Yamamoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Previously Treated Patients ◽

Previously Treated ◽

Download Full-text

Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-Small Cell Lung Cancer: SQUAT trial (WJOG 12119L)

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.04.006 ◽

2021 ◽

Author(s):

Akira Hamada ◽

Junichi Soh ◽

Akito Hata ◽

Kiyoshi Nakamatsu ◽

Mototsugu Shimokawa ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Adjuvant Immunotherapy

Download Full-text

Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer

Cancer ◽

10.1002/1097-0142(19940815)74:4<1243::aid-cncr2820740411>3.0.co;2-d ◽

1994 ◽

Vol 74 (4) ◽

pp. 1243-1252 ◽

Author(s):

Margaret Deutsch ◽

Jeffrey Crawford ◽

Kenneth Leopold ◽

Walter Wolfe ◽

William Foster ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung

Download Full-text

Epirubicin in extensive small-cell lung cancer: A phase II study in previously untreated patients: A National Cancer Institute of Canada Clinical Trials Group Study

Lung Cancer ◽

10.1016/0169-5002(90)90224-a ◽

1990 ◽

Vol 6 (3-4) ◽

pp. 139

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

National Cancer Institute ◽

Phase Ii Study ◽

Small Cell Lung

Download Full-text

A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01)

10.18632/oncotarget.13056 ◽

2016 ◽

Vol 8 (9) ◽

pp. 15943-15951 ◽

Author(s):

Hye Ryun Kim ◽

Joung Soon Jang ◽

Jong-Mu Sun ◽

Myung-Ju Ahn ◽

Dong-Wan Kim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

Platinum Based Chemotherapy

Download Full-text